These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 11441288)

  • 1. [Chemotherapy of colorectal cancer--which therapy is justified for elderly patients?].
    Honecker F; Wedding U; Kolb G; Bokemeyer C
    Onkologie; 2001 Feb; 24(1):87-94. PubMed ID: 11441288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Therapy of elderly patients with colorectal carcinoma].
    Honecker F; Kolb G; Bokemeyer C
    Wien Med Wochenschr; 2002; 152(7-8):170-6. PubMed ID: 12017742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
    Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Insight: Metastatic colorectal cancer--oral fluoropyrimidines and new perspectives in the adjuvant setting.
    Folprecht G; Köhne CH
    Nat Clin Pract Oncol; 2005 Nov; 2(11):578-87. PubMed ID: 16270098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colorectal cancer in the elderly: is palliative chemotherapy of value?
    Honecker F; Köhne CH; Bokemeyer C
    Drugs Aging; 2003; 20(1):1-11. PubMed ID: 12513112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy in elderly patients with colorectal cancer.
    Köhne CH; Folprecht G; Goldberg RM; Mitry E; Rougier P
    Oncologist; 2008 Apr; 13(4):390-402. PubMed ID: 18448553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doublet chemotherapy vs. single-agent therapy with 5FU in elderly patients with metastatic colorectal cancer. a meta-analysis.
    Landre T; Uzzan B; Nicolas P; Aparicio T; Zelek L; Mary F; Taleb C; Des Guetz G
    Int J Colorectal Dis; 2015 Oct; 30(10):1305-10. PubMed ID: 26099322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemotherapy of advanced colorectal carcinoma: treatment options for elderly patients].
    Bokemeyer C; Honecker F
    Onkologie; 2003 Dec; 26 Suppl 7():48-53. PubMed ID: 14716143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent results of irinotecan therapy in colorectal cancer].
    Láng I; Hitre E
    Magy Onkol; 2004; 48(4):281-8. PubMed ID: 15655572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adjuvant and palliative chemotherapy of colorectal cancer in Germany outside controlled trials].
    Lamberti C; Lundin S; Bogdanow M; Gorschlüter M; Schmidt-Wolf IG; Sauerbruch T
    Dtsch Med Wochenschr; 2006 Mar; 131(10):485-90. PubMed ID: 16511737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metronomic 5-fluorouracil, oxaliplatin and irinotecan in colorectal cancer.
    Fioravanti A; Canu B; Alì G; Orlandi P; Allegrini G; Di Desidero T; Emmenegger U; Fontanini G; Danesi R; Del Tacca M; Falcone A; Bocci G
    Eur J Pharmacol; 2009 Oct; 619(1-3):8-14. PubMed ID: 19695243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemotherapy for colorectal cancers].
    Lièvre A; Mitry E
    J Chir (Paris); 2003 Feb; 140(1):52-5. PubMed ID: 12709655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irinotecan or oxaliplatin combined with 5-fluorouracil and leucovorin as first-line therapy for advanced colorectal cancer: a meta-analysis.
    Liang XB; Hou SH; Li YP; Wang LC; Zhang X; Yang J
    Chin Med J (Engl); 2010 Nov; 123(22):3314-8. PubMed ID: 21163137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxaliplatin, folinic acid and 5-fluorouracil (FOLFOX-4) combination chemotherapy as second-line treatment in advanced colorectal cancer patients with irinotecan failure: a Korean single-center experience.
    Park SH; Sung JY; Han SH; Baek JH; Oh JH; Bang SM; Cho EK; Shin DB; Lee JH
    Jpn J Clin Oncol; 2005 Sep; 35(9):531-5. PubMed ID: 16027146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of adjuvant therapy for colorectal cancer.
    O'Connell MJ
    Oncology (Williston Park); 2004 May; 18(6):751-5; discussion 755-8. PubMed ID: 15214594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of irinotecan and oxaliplatin in the treatment of advanced colorectal cancer.
    Khayat D; Gil-Delgado M; Antoine EC; Nizri D; Bastian G
    Oncology (Williston Park); 2001 Apr; 15(4):415-29; discussion 429-30, 433-4. PubMed ID: 11346931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic advances in the management of metastatic colorectal cancer.
    Freyer G; Ligneau B; Kraft D; Descos L; Trillet-Lenoir V
    Expert Rev Anticancer Ther; 2001 Aug; 1(2):236-46. PubMed ID: 12113029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I clinical and pharmacokinetic/pharmacogenetic study of a triplet regimen of S-1/irinotecan/oxaliplatin in patients with metastatic colorectal or gastric cancer.
    Park SR; Hong YS; Lim HS; Seong MW; Kong SY; Kim SY; Park YI; Jung KH
    Cancer Chemother Pharmacol; 2013 Nov; 72(5):953-64. PubMed ID: 23982118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of reintroduction of oxaliplatin for advanced colorectal cancer in patients previously treated with oxaliplatin and irinotecan: RE-OPEN study.
    Suenaga M; Mizunuma N; Matsusaka S; Shinozaki E; Ozaka M; Ogura M; Yamaguchi T
    Drug Des Devel Ther; 2015; 9():3099-108. PubMed ID: 26124634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapy of elderly patients with colorectal cancer].
    Landherr L; Nagykálnai T
    Magy Onkol; 2009 Jun; 53(2):97-105. PubMed ID: 19581175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.